Latest filing published 20 Dec 2021 for Immix Biopharma, Inc., €8,676.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Vladimir P. Torchilin: trading record in brief
Vladimir P. Torchilin, listed as chief executive, appears in our data through filings on Immix Biopharma, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 17 December 2021 and the latest from 20 December 2021.
No open-market sale appears; the market trades are 2 purchases worth €22k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 20 December 2021 with an open-market purchase (€13k) in Immix Biopharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Vladimir P. Torchilin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,200 shares@ US$4.47100.0% of flowCommon StockSEC:0001493152-21-032036:0Canonical exit: 17 Mar 2022 (T+90)
1 of 1 declaration
